Research I 04 February 2026 OECD cites EuroACT data in the new report on High Value Cancer Care We are proud to share that the Organisation for Economic Co-operation and Development (OECD-OCDE) has published its 2026 report Delivering Hight Value Cancer Care, and EuroACT data has played a key role in shaping it. The report can be accessed here: https://lnkd.in/eRsupumz EuroACT insights
Research I 03 November 2025 Our haematological diseases preprint is now available on Preprints with The Lancet! Read it here: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5646744 Title: Variation in Use of Patient-Reported Outcome Measures and in Geographical Distribution in Clinical Trials of Selected Malignant and Non-Malignant Haematological Diseases in Europe: Findings from EuroACT This study analysed data
Research I 20 October 2025 Best Poster Award at ESMO 2025! The EuroACT project was featured Sunday 19th October 2025 at ESMO 2025 Congress showcasing our work on mapping the European clinical trial landscape. We are proud to share that our poster received the Best Poster Award, recognising its outstanding clarity of
Research I 18 August 2025 Recognition for EuroACT: Collaborating with OECD on European Health Policy We are pleased to share that the Organisation for Economic Co-operation and Development (OECD) contacted us after discovering our European Atlas on Clinical Trials in Cancer and Hematology (EuroACT) work on our website. This marks an exciting
Research I 6 August 2025 EuroACT Phase 3: Advancing from data to evidence EuroACT Phase 3: Conversion – Data becomes evidence is well underway! This phase builds on the foundations of Phases 1 and 2, focusing on interpreting and iterating our findings to formulate evidence-based messages and impactful advocacy points for the